Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
boston blog main
4
×
boston top stories
life sciences
national blog main
national top stories
startups
4
×
boston
new york blog main
new york top stories
biogen
clinical trials
deals
drug discovery
investing
ptc therapeutics
san francisco blog main
san francisco top stories
vc
venture capital
accent therapeutics
aducanumab
allosteric
alzheimer's disease
amblyotech
antisense oligonucleotide
asklepios biopharmaceutical
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
benzodiazepines
beta-thalassemia
bioeurope
biomarin pharmaceutical
blackstone group
blackstone life sciences
boulder/denver blog main
boulder/denver top stories
brace pharma
What
medicines
4
×
new
4
×
aims
developing
drugs
research
therapeutics
activity
address
adds
ago
allosteric
approach
approvals
backed
based
bio
biogen
biotech
called
cause
ceo
clamped
clinic
covid
debuts
delays
disease
economic
elusive
epigenetic
epigenetics
epilepsy
fast
fda
field
flagship’s
genes
genetic
hotspot
Language
unset
4
×
Current search:
new
×
startups
×
photo
×
medicines
×
" boston blog main "
×
unset
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further